Valvular heart disease

Common Name(s)

Valvular heart disease

Valvular heart disease refers to diseases that affect any of the four heart valves. Of the four heart valves, two are on the right, the pulmonary and tricuspid valves. The other two are on the left; they are the aortic and mitral valves. Valvular heart disease can be present at birth (congenital) or it can be acquired later in life. Blood normally flows in one direction through the valves due to the forces of the heartbeats. With the disease, the valves become hardened, narrow, or are unable to close properly, which can allow blood to travel in the wrong direction or at the wrong time.

Some people with valvular heart disease never have noticeable symptoms. In those that do, symptoms may include a racing or very hard heartbeat (palpitations), fatigue, dizziness, fever, and rapid weight gain. The risk of valvular heart disease increases with age. Most people diagnosed with the disease are older than 50, and many are older than 75. Acquired valvular heart disease is often caused by another disease or infection; the most common causes are rheumatic fever and endocarditis. Other risk factors for the disease include smoking cigarettes, abusing alcohol, being overweight, and uncontrolled blood sugar for people with diabetes.

In order to diagnose the disease, your doctor will perform a physical exam. They may listen to your heartbeat for a swishing sound (a murmur). The doctor may also suggest tests to confirm the diagnosis such as MRIs or they may try to see into your heart using an angiogram. There are medications available for treatment. However, in more severe cases, surgery to replace the valve may be necessary. If you have been diagnosed with valvular heart disease, talk to your doctor and cardiologist about the most current treatment options. Support organizations are also a good source of information and will help connect you with others living with valvular heart disease.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Valvular heart disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Valvular heart disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Valvular heart disease" returned 182 free, full-text research articles on human participants. First 3 results:

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGEĀ AF-TIMI 48 Trial.
 

Author(s): Raffaele De Caterina, Giulia Renda, Anthony P Carnicelli, Francesco Nordio, Marco Trevisan, Michele F Mercuri, Christian T Ruff, Elliott M Antman, Eugene Braunwald, Robert P Giugliano

Journal: J. Am. Coll. Cardiol.. 2017 Mar;69(11):1372-1382.

 

The use of non-vitamin K antagonist oral anticoagulants (NOACs) instead of vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and coexisting valvular heart disease (VHD) is of substantial interest.

Last Updated: 17 Mar 2017

Go To URL
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
 

Author(s): Giulia Renda, Fabrizio Ricci, Robert P Giugliano, Raffaele De Caterina

Journal: J. Am. Coll. Cardiol.. 2017 Mar;69(11):1363-1371.

 

Valvular heart disease (VHD) and atrial fibrillation (AF) often coexist. Phase III trials comparing non-vitamin K antagonist oral anticoagulants (NOACs) with warfarin excluded patients with moderate/severe mitral stenosis or mechanical heart valves, but variably included patients ...

Last Updated: 17 Mar 2017

Go To URL
Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
 

Author(s): Christophe Baufreton, Patrick Bruneval, Marie-Christine Rousselet, Pierre-Vladimir Ennezat, Olivier Fouquet, Raphael Giraud, Carlo Banfi

Journal: Medicine (Baltimore). 2017 Jan;96(2):e4985.

 

Drug-induced valvular heart disease (DI-VHD) remains an under-recognized entity.

Last Updated: 12 Jan 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Valvular heart disease" returned 81 free, full-text review articles on human participants. First 3 results:

Interventional Cardiology: Current Status and Future Directions in Coronary Disease and Valvular Heart Disease.
 

Author(s): David P Faxon, David O Williams

Journal: Circulation. 2016 Jun;133(25):2697-711.

 

Last Updated: 21 Jun 2016

Go To URL
Valvular heart disease in pregnancy.
 

Author(s): John Anthony, Ayesha Osman, Mahmoud U Sani

Journal: Cardiovasc J Afr. ;27(2):111-8.

 

Valvular heart disease may be a pre-existing complication of pregnancy or it may be diagnosed for the first time during pregnancy. Accurate diagnosis, tailored therapy and an understanding of the physiology and pathophysiology of pregnancy are necessary components of management, best ...

Last Updated: 24 May 2016

Go To URL
Operationalizing the 2014 ACC/AHA Guidelines for Valvular Heart Disease: A Guide for Clinicians.
 

Author(s): Rick A Nishimura, Blase Carabello

Journal: J. Am. Coll. Cardiol.. 2016 May;67(19):2289-94.

 

The 2014 American College of Cardiology/American Heart Association guidelines for valvular heart disease were released to help guide the clinician in caring for patients with this ever more prevalent and complex group of diseases and have been instrumental in providing a foundation ...

Last Updated: 13 May 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University
 

Status: Not yet recruiting

Condition Summary: Valvular Heart Disease

 

Last Updated: 4 Jan 2017

Go to URL
China Senile Valvular Heart Disease Cohort Study
 

Status: Not yet recruiting

Condition Summary: Heart Valve Diseases

 

Last Updated: 10 Aug 2016

Go to URL
RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
 

Status: Recruiting

Condition Summary: Valvular Heart Disease

 

Last Updated: 15 Dec 2016

Go to URL